Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.
2.

An Attempt to Stem the Tide: Exploring the Effect of a 90-Day Transitional Care Intervention on Readmissions to an Acute Male Psychiatric Unit in South Africa.

Botha UA, Coetzee M, Koen L, Niehaus DJH.

Arch Psychiatr Nurs. 2018 Jun;32(3):384-389. doi: 10.1016/j.apnu.2017.12.002. Epub 2017 Dec 5.

PMID:
29784219
3.

The effect of an occupational therapy mental health day treatment centre on the use of inpatient services in the Western Cape, South Africa.

Engelbrecht R, Plastow N, Botha U, Niehaus D, Koen L.

Disabil Rehabil. 2018 Apr 27:1-7. doi: 10.1080/09638288.2018.1453873. [Epub ahead of print]

PMID:
29701509
4.

Risk factors for unplanned pregnancy in women with mental illness living in a developing country.

du Toit E, Jordaan E, Niehaus D, Koen L, Leppanen J.

Arch Womens Ment Health. 2018 Jun;21(3):323-331. doi: 10.1007/s00737-017-0797-7. Epub 2017 Nov 9.

PMID:
29124444
5.

Mothers' pupillary responses to infant facial expressions.

Yrttiaho S, Niehaus D, Thomas E, Leppänen JM.

Behav Brain Funct. 2017 Feb 6;13(1):2. doi: 10.1186/s12993-017-0120-9.

6.

Brief Report: A Randomized Control Trial Assessing the Influence of a Telephone-based Intervention on Readmissions for Patients with Severe Mental Illness in a Developing Country.

Botha UA, Koen L, Mazinu M, Jordaan E, Niehaus DJH.

Community Ment Health J. 2018 Feb;54(2):197-203. doi: 10.1007/s10597-016-0069-4. Epub 2016 Nov 30.

7.

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.

Drögemöller BI, Emsley R, Chiliza B, van der Merwe L, Wright GE, Daya M, Hoal E, Malhotra AK, Lencz T, Robinson DG, Zhang JP, Asmal L, Niehaus DJ, Warnich L.

Pharmacogenet Genomics. 2016 May;26(5):235-42. doi: 10.1097/FPC.0000000000000213.

PMID:
26928376
8.

Facial affect recognition and exit examination performance in medical students: a prospective exploratory study.

Roos TC, Niehaus DJ, Leppänen JM, Ras J, Cloete KJ, Jordaan E, Koen L.

BMC Med Educ. 2014 Nov 28;14:245. doi: 10.1186/s12909-014-0245-6.

9.

Religious Delusions in a Xhosa Schizophrenia Population.

Connell A, Koen L, Niehaus D, Cloete KJ, Jordaan E, Botha U.

J Relig Health. 2015 Oct;54(5):1555-62. doi: 10.1007/s10943-014-9860-0.

PMID:
24711217
10.

Association study in three different populations between the GPR88 gene and major psychoses.

Del Zompo M, Deleuze JF, Chillotti C, Cousin E, Niehaus D, Ebstein RP, Ardau R, Macé S, Warnich L, Mujahed M, Severino G, Dib C, Jordaan E, Murad I, Soubigou S, Koen L, Bannoura I, Rocher C, Laurent C, Derock M, Faucon Biguet N, Mallet J, Meloni R.

Mol Genet Genomic Med. 2014 Mar;2(2):152-9. doi: 10.1002/mgg3.54. Epub 2013 Dec 12.

11.
12.

Patterns of variation influencing antipsychotic treatment outcomes in South African first-episode schizophrenia patients.

Drogemöller BI, Niehaus DJ, Chiliza B, van der Merwe L, Asmal L, Malhotra AK, Wright GE, Emsley R, Warnich L.

Pharmacogenomics. 2014 Feb;15(2):189-99. doi: 10.2217/pgs.13.218.

PMID:
24444409
13.

Attempted suicide in a Xhosa schizophrenia and schizoaffective disorder population.

Lückhoff M, Koen L, Jordaan E, Niehaus D.

Suicide Life Threat Behav. 2014 Apr;44(2):167-74. doi: 10.1111/sltb.12066. Epub 2013 Nov 29.

PMID:
24286498
14.

Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment.

Drögemöller BI, Wright GE, Niehaus DJ, Emsley R, Warnich L.

Pharmacogenet Genomics. 2013 Dec;23(12):666-74. doi: 10.1097/FPC.0000000000000006.

PMID:
24141736
15.

Characterization of the genetic variation present in CYP3A4 in three South African populations.

Drögemöller B, Plummer M, Korkie L, Agenbag G, Dunaiski A, Niehaus D, Koen L, Gebhardt S, Schneider N, Olckers A, Wright G, Warnich L.

Front Genet. 2013 Feb 18;4:17. doi: 10.3389/fgene.2013.00017. eCollection 2013.

16.

Comparison of treatment response in second-episode versus first-episode schizophrenia.

Emsley R, Oosthuizen P, Koen L, Niehaus D, Martinez L.

J Clin Psychopharmacol. 2013 Feb;33(1):80-3. doi: 10.1097/JCP.0b013e31827bfcc1.

PMID:
23277247
17.

Retrospective review of trends in assaults and seclusion at an acute psychiatric ward over a 5-year period.

Luckhoff M, Jordaan E, Swart Y, Cloete KJ, Koen L, Niehaus DJ.

J Psychiatr Ment Health Nurs. 2013 Oct;20(8):687-95. doi: 10.1111/jpm.12006. Epub 2012 Sep 19.

PMID:
22988983
18.

Metabolic effects of paliperidone extended release versus oral olanzapine in patients with schizophrenia: a prospective, randomized, controlled trial.

Schreiner A, Niehaus D, Shuriquie NA, Aadamsoo K, Korcsog P, Salinas R, Theodoropoulou P, Fernández LG, Uçok A, Tessier C, Bergmans P, Hoeben D.

J Clin Psychopharmacol. 2012 Aug;32(4):449-57. doi: 10.1097/JCP.0b013e31825cccad. Erratum in: J Clin Psychopharmacol. 2012 Dec;32(6):803.

PMID:
22722501
19.

Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort.

Wright GE, Niehaus DJ, van der Merwe L, Koen L, Korkie LJ, Kinnear CJ, Drögemöller BI, Warnich L.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):163-9. doi: 10.1016/j.pnpbp.2012.06.006. Epub 2012 Jun 13.

PMID:
22705295
20.

Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.

Emsley R, Oosthuizen PP, Koen L, Niehaus DJ, Martinez G.

J Clin Psychiatry. 2012 Apr;73(4):e541-7. doi: 10.4088/JCP.11m07138.

PMID:
22579160
21.

Neurological soft signs as an endophenotype in an African schizophrenia population - a pilot study.

Smit I, Koen L, Niehaus DJ, Jordaan E, Botha UA.

Afr J Psychiatry (Johannesbg). 2012 Mar;15(2):124-7. doi: http://dx.doi.org/10.4314/ajpsy.v15i2.17.

PMID:
22552727
22.

Applicability and fairness of the oral examination in undergraduate psychiatry training in South Africa.

Niehaus DJ, Jordaan E, Koen L, Mashile M, Mall S.

Afr J Psychiatry (Johannesbg). 2012 Mar;15(2):119-23. doi: http://dx.doi.org/10.4314/ajpsy.v15i2.16.

23.

Chromosome 22q11 in a Xhosa schizophrenia population.

Koen L, Niehaus DJ, Wright G, Warnich L, De Jong G, Emsley RA, Mall S.

S Afr Med J. 2012 Feb 23;102(3 Pt 1):165-6.

PMID:
22380913
24.

Psychiatric genetics in South Africa: cutting a rough diamond.

Wright GE, Niehaus DJ, Koen L, Drögemöller BI, Warnich L.

Afr J Psychiatry (Johannesbg). 2011 Nov;14(5):355-66. doi: http://dx.doi.org/10.4314/ajpsy.v14i5.2. Review.

PMID:
22183465
25.

Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications.

Drögemöller BI, Wright GE, Niehaus DJ, Emsley RA, Warnich L.

Pharmacogenomics. 2011 Dec;12(12):1717-28. doi: 10.2217/pgs.11.119.

PMID:
22118054
26.

Characterization of the genetic profile of CYP2C19 in two South African populations.

Drögemöller BI, Wright GE, Niehaus DJ, Koen L, Malan S, Da Silva DM, Hillermann-Rebello R, La Grange AM, Venter M, Warnich L.

Pharmacogenomics. 2010 Aug;11(8):1095-103. doi: 10.2217/pgs.10.90.

PMID:
20712527
27.

Subjective awareness of tardive dyskinesia and insight in schizophrenia.

Emsley R, Niehaus DJ, Oosthuizen PP, Koen L, Chiliza B, Fincham D.

Eur Psychiatry. 2011 Jul-Aug;26(5):293-6. doi: 10.1016/j.eurpsy.2009.12.006. Epub 2010 Jul 8.

PMID:
20615668
28.

Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population.

Wright GE, Niehaus DJ, Drögemöller BI, Koen L, Gaedigk A, Warnich L.

Ann Hum Genet. 2010 Jul;74(4):340-50. doi: 10.1111/j.1469-1809.2010.00585.x.

29.

Antipsychotic prescription patterns in Xhosa patients with schizophrenia or schizoaffective disorder.

Koen L, Magni P, Niehaus DJ, le Roux A.

Afr J Psychiatry (Johannesbg). 2008 Nov;11(4):287-90.

PMID:
19588052
30.

The multidimensional assessment of psychopathology in mood and psychotic disorders. A proposal for Axis II in DSM-V/ICD-11.

Oosthuizen P, Emsley R, Niehaus D, Koen L.

Afr J Psychiatry (Johannesbg). 2008 Nov;11(4):260-3.

PMID:
19588047
31.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
32.

Allocation of attention to the eye and mouth region of faces in schizophrenia patients.

Leppänen JM, Niehaus DJ, Koen L, Schoeman R, Emsley R.

Cogn Neuropsychiatry. 2008 Nov;13(6):505-19. doi: 10.1080/13546800802608452.

PMID:
19048442
33.

Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial.

Emsley R, Niehaus DJ, Oosthuizen PP, Koen L, Ascott-Evans B, Chiliza B, van Rensburg SJ, Smit RM.

Psychiatry Res. 2008 Dec 15;161(3):284-91. doi: 10.1016/j.psychres.2007.06.029. Epub 2008 Oct 29.

PMID:
18962989
34.

Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Int Clin Psychopharmacol. 2008 Nov;23(6):325-31. doi: 10.1097/YIC.0b013e32830c2042.

PMID:
18854720
35.

Predictors of abnormal involuntary movement in an african schizophrenia population.

Niehaus DJ, du Plessis SA, Koen L, Lategan BH, Steyn J, Oosthuizen PP, Warnich L, Emsley RA.

J Neuropsychiatry Clin Neurosci. 2008 Summer;20(3):317-26. doi: 10.1176/appi.neuropsych.20.3.317.

PMID:
18806235
36.

Crisis discharges and readmission risk in acute psychiatric male inpatients.

Niehaus DJ, Koen L, Galal U, Dhansay K, Oosthuizen PP, Emsley RA, Jordaan E.

BMC Psychiatry. 2008 Jun 17;8:44. doi: 10.1186/1471-244X-8-44.

37.

Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study.

Emsley R, Medori R, Koen L, Oosthuizen PP, Niehaus DJ, Rabinowitz J.

J Clin Psychopharmacol. 2008 Apr;28(2):210-3. doi: 10.1097/JCP.0b013e318167269d. Erratum in: J Clin Psychopharmacol. 2008 Dec;28(6):624.

PMID:
18344732
38.

Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial.

Muller JE, Wentzel I, Koen L, Niehaus DJ, Seedat S, Stein DJ.

Int Clin Psychopharmacol. 2008 Jan;23(1):43-8.

PMID:
18090507
39.

Deficits in facial affect recognition in unaffected siblings of Xhosa schizophrenia patients: evidence for a neurocognitive endophenotype.

Leppänen JM, Niehaus DJ, Koen L, Du Toit E, Schoeman R, Emsley R.

Schizophr Res. 2008 Feb;99(1-3):270-3. Epub 2007 Dec 4.

PMID:
18055176
40.

HIV/AIDS risk behaviour in South African schizophrenia patients.

Koen L, Vuuren SV, Niehaus DJ, Emsley RA.

West Afr J Med. 2007 Jan-Mar;26(1):2-6.

PMID:
17595982
41.

Initiation rites as a perceived stressor for Isixhosa males with schizophrenia.

le Roux R, Niehaus DJ, Koen L, Seller C, Lochner C, Emsley RA.

Transcult Psychiatry. 2007 Jun;44(2):292-9.

PMID:
17576730
42.

Negative symptoms and HIV/AIDS risk-behavior knowledge in schizophrenia.

Koen L, Uys S, Niehaus DJ, Emsley RA.

Psychosomatics. 2007 Mar-Apr;48(2):128-34.

PMID:
17329606
43.

Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.

Hitzeroth A, Niehaus DJ, Koen L, Botes WC, Deleuze JF, Warnich L.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):664-72. Epub 2007 Jan 12.

PMID:
17291655
44.

Remission in first-episode psychosis: predictor variables and symptom improvement patterns.

Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ.

J Clin Psychiatry. 2006 Nov;67(11):1707-12.

PMID:
17196049
45.

The relationships between depression and remission in first-episode psychosis.

Oosthuizen P, Emsley R, Niehaus D, Koen L, Chiliza B.

World Psychiatry. 2006 Oct;5(3):172-6.

46.

Morphological features in a Xhosa schizophrenia population.

Koen L, Niehaus DJ, De Jong G, Muller JE, Jordaan E.

BMC Psychiatry. 2006 Oct 27;6:47.

47.

Genetic variability in CHMP2B and frontotemporal dementia.

Momeni P, Rogaeva E, Van Deerlin V, Yuan W, Grafman J, Tierney M, Huey E, Bell J, Morris CM, Kalaria RN, van Rensburg SJ, Niehaus D, Potocnik F, Kawarai T, Salehi-Rad S, Sato C, St George-Hyslop P, Hardy J.

Neurodegener Dis. 2006;3(3):129-33.

PMID:
16954699
48.

Topiramate in the treatment of trichotillomania: an open-label pilot study.

Lochner C, Seedat S, Niehaus DJ, Stein DJ.

Int Clin Psychopharmacol. 2006 Sep;21(5):255-9.

PMID:
16877895
49.

Season of birth, age and negative symptoms in a Xhosa schizophrenia sample from the Southern Hemisphere.

Jordaan E, Niehaus DJ, Koen L, Seller C, Mbanga I, Emsley RA.

Aust N Z J Psychiatry. 2006 Aug;40(8):698-703.

PMID:
16866766
50.

A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder.

Warwick JM, Carey P, Van der Linden G, Prinsloo C, Niehaus D, Seedat S, Dupont P, Stein DJ.

Metab Brain Dis. 2006 Sep;21(2-3):241-52. Epub 2006 Jul 19.

PMID:
16850261

Supplemental Content

Loading ...
Support Center